With the growing awareness of the impact of chronic back pain and axial spondyloarthritis
and recent breakthroughs in genetics and the development of novel treatments which may …

Introduction: Osteoporosis is the commonest metabolic bone disease worldwide. The clinical
hallmark of osteoporosis is low trauma fracture, with the most devastating being hip fracture …

Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects 1% of the general
population. As one of the most severe types of spondyloarthropathy, AS affects the spinal …

Cyclooxygenases (COX-1 and COX-2) are key enzymes in several physiopathological
processes. Many adverse drugs reactions to NSAIDs are attributable to COX-inhibition. The …

Ankylosing spondylitis (AS) is the most common form of spondyloarthritis and is
characterized by both inflammation and new bone formation. Despite many years of arduous …

Objectives To investigate DKK-1 and SOST serum levels among patients with recent
inflammatory back pain (IBP) fulfilling ASAS criteria for SpA and associated factors. Methods …

Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) have a well-established
analgesic efficacy for inflammatory pain. These drugs exert their effect by inhibiting the …

Biomarkers in axial spondyloarthritis : Current Opinion in Rheumatology Biomarkers in axial
spondyloarthritis : Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe …

In the last few years, many studies have investigated the role of imaging for improved
diagnosis, assessment of treatment effects, and determining prognosis in patients with axial …

Support: The symposium was jointly organised and funded by Novartis Pharmaceuticals. All
authors received honoraria for preparation and delivery of their presentations. The …